Esteves Lisa M, Bulhões Sara M, Brilhante Maria J, Mota-Vieira Luisa
Molecular Genetics and Pathology Unit, Hospital of Divino Espírito Santo of Ponta Delgada, EPE, São Miguel Island, Azores, Portugal.
BMC Res Notes. 2013 Feb 7;6:54. doi: 10.1186/1756-0500-6-54.
Innate immune system is the first line of research when studying immune response to diverse infections and autoimmune/inflammatory diseases. This immune response has been reported to be genetically diverse, due to polymorphisms coded by different genes. For this reason, our purpose was to develop a multiplex assay that allows the genotyping of candidate single nucleotide polymorphisms (SNPs) in innate immune genes.
We developed three multiplex PCR panels coupled with the minisequencing (SNaPshot) technique (multiplex PCR, multiplex primer extension, and capillary electrophoresis). The panels were tested in a sample set composed of 100 anonymous DNAs from healthy blood donors living in São Miguel Island (Azores, Portugal). Sixteen relevant SNPs among nine genes of the innate immune system--IL1α, IL1β, IL6, IL10, IL12RB1, TLR2, TLR4, TLR9 and CD14--were genotyped and validated by direct sequencing, with the exception of one that was undetected by minisequencing. We suggest that these panels can be used in future studies for detection of risk gene variants in several populations and/or diseases.
In summary, we propose a multiplex assay that is able to identify the most frequent candidate SNPs in innate immune genes, using a medium scale genotyping platform. The assays can be used to evaluate the risk gene variants in populations of various geographic origins.
在研究对多种感染以及自身免疫性/炎症性疾病的免疫反应时,先天性免疫系统是首要的研究对象。据报道,由于不同基因编码的多态性,这种免疫反应在基因上具有多样性。因此,我们的目的是开发一种多重检测方法,用于对先天性免疫基因中的候选单核苷酸多态性(SNP)进行基因分型。
我们开发了三个与微测序(SNaPshot)技术相结合的多重PCR面板(多重PCR、多重引物延伸和毛细管电泳)。这些面板在一组由来自居住在圣米格尔岛(葡萄牙亚速尔群岛)的100名健康献血者的匿名DNA组成的样本中进行了测试。对先天性免疫系统九个基因(IL1α、IL1β、IL6、IL10、IL12RB1、TLR2、TLR4、TLR9和CD14)中的16个相关SNP进行了基因分型,并通过直接测序进行了验证,但有一个SNP未被微测序检测到。我们建议这些面板可用于未来的研究,以检测多个群体和/或疾病中的风险基因变异。
总之,我们提出了一种多重检测方法,该方法能够使用中等规模的基因分型平台识别先天性免疫基因中最常见的候选SNP。这些检测方法可用于评估不同地理来源人群中的风险基因变异。